PMID- 26335635
OWN - NLM
STAT- MEDLINE
DCOM- 20151215
LR  - 20150904
IS  - 1661-4127 (Electronic)
IS  - 1661-4119 (Linking)
VI  - 22
IP  - 3
DP  - 2015
TI  - HIV Nosode: The Homeopathic Pathogenetic Trial.
PG  - 156-62
LID - 10.1159/000435845 [doi]
AB  - BACKGROUND: Deriving clinical indications for the HIV nosode by conducting a 
      double-blind, placebo-controlled homeopathic pathogenetic trial (HPT) with the 
      aim to introduce a new nosode to the profession. METHOD: The HPT was conducted in 
      22 volunteers, 15 of which received HIV nosode in 30c potency pills, while 7 
      received identical placebo pills orally, once a week, for 4 weeks. The 
      volunteers' symptoms during initial 7 days of run-in period were noted. All 
      symptoms for both groups produced during run-in period were excluded from final 
      analysis. Informed consent form, approval by Ethics Committee, laboratory 
      investigations as well as safety and ethical measures were provided. The 
      volunteers were trained to write data in prescribed diaries, and the data were 
      analyzed. RESULTS: The HPT of the HIV nosode exhibited qualitatively distinct 
      symptoms, which can be applied in clinical practice. Number of symptoms reported 
      in verum group was 130, in placebo group 60. Quantitative pathogenetic index was 
      0.285 in verum group, 0.238 in placebo group; qualitative pathogenetic index was 
      0.1402 in the verum group as compared to placebo (0.0907). Safe use was 
      documented. CONCLUSION: This study brought in guiding symptoms, which will help 
      the profession to employ this nosode in practice.
CI  - (c) 2015 S. Karger GmbH, Freiburg.
FAU - Shah, Rajesh
AU  - Shah R
AD  - Life Force, Mumbai, India.
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20150623
PL  - Switzerland
TA  - Forsch Komplementmed
JT  - Forschende Komplementarmedizin (2006)
JID - 101269884
RN  - 0 (Materia Medica)
SB  - IM
MH  - Adult
MH  - *HIV
MH  - Homeopathy/*methods
MH  - Humans
MH  - Male
MH  - Materia Medica/administration & dosage/*adverse effects
EDAT- 2015/09/04 06:00
MHDA- 2015/12/17 06:00
CRDT- 2015/09/04 06:00
PHST- 2015/09/04 06:00 [entrez]
PHST- 2015/09/04 06:00 [pubmed]
PHST- 2015/12/17 06:00 [medline]
AID - 000435845 [pii]
AID - 10.1159/000435845 [doi]
PST - ppublish
SO  - Forsch Komplementmed. 2015;22(3):156-62. doi: 10.1159/000435845. Epub 2015 Jun 
      23.